TF
TNDM icon

TimeScale Financial’s Tandem Diabetes Care TNDM Stock Holding History

TimeScale Financial’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$1.05K Hold
43
– – ﹤0.01% 544
2023
Q1 		$1.75K Hold
43
– – ﹤0.01% 491
2022
Q4 		$2.06K Hold
43
– – ﹤0.01% 454
2022
Q3 		$2K Buy
+43
New +$2.36K ﹤0.01% 469

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

TimeScale Financial's TNDM Position: Q2 2023 in Review

TimeScale Financial held its Tandem Diabetes Care (TNDM) position steady in Q2 2023 at 43 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #544.

TimeScale Financial first reported a position in TNDM in Q3 2022 and has held it in 4 quarters since. The position peaked at $2.06K in Q4 2022. 247 funds tracked by Wall St. Rank hold TNDM as of Q2 2023.

  • TimeScale Financial held 43 shares of Tandem Diabetes Care worth $1.05K as of Q2 2023.
  • TimeScale Financial left its Tandem Diabetes Care share count unchanged in Q2 2023.
  • Tandem Diabetes Care made up ﹤0.01% of TimeScale Financial's portfolio in Q2 2023, its #544 holding.
  • TimeScale Financial first reported a position in Tandem Diabetes Care in Q3 2022 and has held it in 4 quarters since.
  • TimeScale Financial's Tandem Diabetes Care position peaked at $2.06K in Q4 2022.
  • 247 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.